Cosentyx (Secukinumab) Injection 150?mg/mL Pre?filled Syringe – (For Research Use Only)

DescriptionCosentyx (secukinumab) binds and neutralizes interleukin?17A (IL?17A), a pro?inflammatory cytokine involved in psoriasis, psoriatic arthritis, and ankylosing spondylitis. By blocking IL?17A, secukinumab reduces inflammation and modulates immune signaling. Widely used in research to model autoimmune inflammation, IL?17 signaling dynamics, and test novel anti?cytokine therapies. Administered subcutaneously via 150?mg/mL pre?filled syringe or auto?injector. Packaged as individual syringes. Strictly for laboratory research use only. Contents hide 1 Cosentyx (Secukinumab) Product Specifications 2 Cosentyx (Secukinumab) Mechanism of Action & Research Applications 3 Cosentyx (Secukinumab) Side Effects (For Reference Only in Research Models) 4 Disclaimer Cosentyx (Secukinumab) Product SpecificationsParameterDetailProduct NameCosentyx (Secukinumab) InjectionConcentration150?mg/mL in 1?mL pre?filled syringeDosage FormSubcutaneous injectable monoclonal antibodyPackaging1 syringe per boxManufacturerNovartis Pharma Stein AGApproval Number???? SJ20190023Drug Standard Code86978679002666BarcodeNot yet assignedCAS Number875356?43?7 (heavy chain), 875356?44?8 (light chain)Molecular TypeHuman IgG1? monoclonal antibody targeting IL?17ACosentyx (Secukinumab) Mechanism of Action & Research ApplicationsSecukinumab is an IL?17A inhibitor that suppresses inflammation by blocking the cytokine signaling cascade mediated via Th17 cells. In research settings, Cosentyx is used to model:Immune-mediated inflammation pathwaysPsoriasiform skin, joint inflammation, and spondyloarthritis modelsIL?17 signaling and cytokine modulation assaysProof-of-concept studies for anti-cytokine therapies in vitro and in vivoCosentyx (Secukinumab) Side Effects (For Reference Only in Research Models)Experimental analogs and clinical data suggest possible observations such as:Upper respiratory infections, nasopharyngitisDiarrhea, oral herpes, rash, or injection-site rednessRare inflammatory bowel disease exacerbationsAnaphylaxis or hypersensitivity in latex-sensitive protocolsMonitor inflammatory markers and model tolerability parameters accordingly.DisclaimerCosentyx (secukinumab) Injection is strictly intended for laboratory research use only. Not for human or veterinary therapeutic or diagnostic use.